Beryl Drugs Ltd — Important, 11-05-2026: Company Update

Beryl Drugs shareholders have approved the regularization of Mr. Shailendra Pathak as Whole-Time Director for five years. Mr. Pathak brings over 35 years of pharmaceutical industry experience, specializing in IV fluids and Oral Solid Doses manufacturing, including plant setup and marketing. His appointment is set to strengthen the company's leadership with deep industry expertise. He will receive a fixed remuneration of Rs. 1.25 lakh per month, alongside a commission of 0.25% on existing product sales and 0.50% on additional product sales. This strategic move aims to leverage his extensive background for business growth.